Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

111,725 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A double-blind, dose-response study of losartan in hypertensive children.
Shahinfar S, Cano F, Soffer BA, Ahmed T, Santoro EP, Zhang Z, Gleim G, Miller K, Vogt B, Blumer J, Briazgounov I. Shahinfar S, et al. Among authors: zhang z. Am J Hypertens. 2005 Feb;18(2 Pt 1):183-90. doi: 10.1016/j.amjhyper.2004.09.009. Am J Hypertens. 2005. PMID: 15752945 Clinical Trial.
Losartan and end-organ protection--lessons from the RENAAL study.
Kowey PR, Dickson TZ, Zhang Z, Shahinfar S, Brenner BM; RENAAL Investigators. Kowey PR, et al. Among authors: zhang z. Clin Cardiol. 2005 Mar;28(3):136-42. doi: 10.1002/clc.4960280307. Clin Cardiol. 2005. PMID: 15813620 Free PMC article. Clinical Trial.
Renin angiotensin aldosterone system blockade and renal disease in patients with type 2 diabetes. An Asian perspective from the RENAAL Study.
Chan JC, Wat NM, So WY, Lam KS, Chua CT, Wong KS, Morad Z, Dickson TZ, Hille D, Zhang Z, Cooper ME, Shahinfar S, Brenner BM, Kurokawa K; Asian RENAAL Study Investigators. Chan JC, et al. Among authors: zhang z. Diabetes Care. 2004 Apr;27(4):874-9. doi: 10.2337/diacare.27.4.874. Diabetes Care. 2004. PMID: 15047641 Clinical Trial.
Albuminuria is a target for renoprotective therapy independent from blood pressure in patients with type 2 diabetic nephropathy: post hoc analysis from the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) trial.
Eijkelkamp WB, Zhang Z, Remuzzi G, Parving HH, Cooper ME, Keane WF, Shahinfar S, Gleim GW, Weir MR, Brenner BM, de Zeeuw D. Eijkelkamp WB, et al. Among authors: zhang z. J Am Soc Nephrol. 2007 May;18(5):1540-6. doi: 10.1681/ASN.2006050445. Epub 2007 Apr 4. J Am Soc Nephrol. 2007. PMID: 17409317 Clinical Trial.
111,725 results
You have reached the last available page of results. Please see the User Guide for more information.